Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration

Clinical Chemistry

Volumn 44, Issue 5, 1998, Pages 939-943

  Gunst, Johan J ^a   Langlois, Michel R ^a   Delanghe, Joris R ^a   De Buyzere, Marc L ^a   Leroux Roels, Geert G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTATHIONE; MYOGLOBIN; THIOL DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; LIVER DISEASE; MALE; MULTIPLE ORGAN FAILURE; MUSCLE ATROPHY; MUSCLE INJURY;

EID: 0031921408     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.5.939     Document Type: Article

References (34)

1. Szasz G, Gerhardt W, Gruler W. Creatine kinase in serun. 5. Effects of thiols on isoenzyme activity during storage at various temperatures. Clin Chem 1978;24:1557-63.
2. Cember H, ed. Introduction to health physics, 2nd ed. New York: Pergamon Press, 1983:71.
3. Lang H, Wurzburg U. Creatine kinase, an enzyme of many forms. Clin Chem 1982;28:1439-47.
4. Wevers R, Hagelauer U, Stein W, Bohner J, Faust U, Van Landeghem A, et al. Indices for the age of the creatine kinase M-chain in the blood. Clin Chim Acta 1985;148:197-210.
5. Delanghe J, De Buyzere M, De Scheerder I, Van Den Abeele AM, Vandenbogaerde J, Wieme R. Significance of low creatine kinase in intensive-care patients [Letter]. Clin Chem 1986;34:713-4.
6. Delanghe J, De Buyzere M, De Scheerder I, Van Rostenberghe H, Faust U, Rodenbach J, et al. Post-transcriptional modification of serum creatine kinase in infected intensive care patients. Clin Chim Acta 1990;187:115-24.
7. Horder M, Elser R, Gerhardt W, Mathieum W, Simpson E. IFCC method for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2) J IFCC 1989;1:130-9.
8. Griffith OW. Glutathione and glutathione disulfide. In: Bergrneier HU, ed. Methods of enzymatic analysis. Vol VIII, 3rd ed. Weinheim: Verlag Chemie, 1984:521-9.
9. Delanghe J, Chapelle J-P, Van Der Schueren S. Quantitative nephelometric assay for determining myoglobin evaluated. Clin Chem 1990;36:1675-8.
10. Pinto P, Kaplan A, Van Dreal P. Aldolase II. Spectrophotometric determination using an ultraviolet procedure. Clin Chem 1969;15: 349-60.
11. Rollo J, Davis J, Ladenson J, McDonald J, Bruns D. Effects of β-mercaptoethanol and chelating agents on the stability and activation of creatine kinase in serum. Clin Chim Acta 1978;87: 189-98.
12. Bruns D, Morgan W, Davis J, Ladenson J. Low apparent creatine kinase activity and prolonged lag phases in serum of patients with metastatic disease: elimination by treatment of sera with sulfhydryl agents. Clin Chem 1976;22:1889-95.
13. Moss DW, Henderson AR. Enzymes. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 2nd ed. Philadelphia: WB Saunders, 1994:735-896.
14. Paroni R, De Vecchi E, Cighetti G, Arcelloni C, Fermo I, Grossi A, Bonini P. HPLC with o-phthalaldehyde precolumn derivatization to measure total, oxidized, and protein-bound glutathione in blood, plasma, and tissue. Clin Chem 1995;41:448-54.
15. Smit M, Buursma A, Bouma J, Gruber M. Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate and alcohol dehydrogenase. J Biol Chem 1987;262:13020-6.
16. Loguercio C, Taranto D, Vitale LM, Beneduce F, Del Vecchio Blanco C. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Radic Biol Med 1996;20:483-8.
17. Crippin J. Acetaminophen hepatotoxicity: potentiation by isoniazid. Am J Gastroenterol 1993;88:590-2.
18. Vogt BL, Richie JP. Fasting-induced depletion of glutathione in the aging mouse [Abstract]. Biochem Pharmacol 1993;46:257-63.
19. Weber H, Wegmann T, eds. Atlas der klinischen Enzymologie. Stuttgart: Georg Thieme Verlag, 1968:34-5.
20. Cavanagh K, Veenendaal M, Kapenga J. Subnormal serum creatine kinase activity in a patient with acute myocardial infarction. Clin Chem 1987;33:1306-7.
21. De Scheerder I, Delanghe J, De Buyzere M, Hollanders G, Clement D, Leroux-Roels G. Low serum creatine kinase in patients with infective endocarditis. Clin Chim Acta 1991;197:117-22.
22. Wei N, Pavlidis B, Tsokos G, Elin RJ, Plotz PH. Clinical significance of low creatine phosphokinase values in patients with connective tissue diseases. JAMA 1981;246:1921-3.
23. Frohlich J. Prolonged illness and creatine kinase activity [Letter]. Clin Chem 1975;21:1343-4.
24. Barnert J, Behr W. Acute viral hepatitis and low values for serum creatine kinase [Letter]. Clin Chem 1985;31:1909-10.
25. Rotenberg Z, Weinberger I, Fuchs J, Davidson E, Erdberg A, Sperling O, et al. Low serum creatine phosphokinase values in patients with acute viral hepatitis. Am J Gastroenterol 1984;79: 276-9.
26. Nanji AA, Blank D. Low serum creatine kinase activity in patients with alcoholic liver disease [Letter]. Clin Chem 1981;27:1954.
27. Roberts R, Ishikawa Y. Enzymatic estimations of infarct size during reperfusion. Circulation 1983;68(Suppl 1):83-9.
28. Delanghe J, De Buyzere M, Cluyse L, Thierens H, Clement D. Acute myocardial infarct size and cumulative myoglobin release in serum. Eur J Clin Chem Clin Biochem 1992;30:823-30.
29. Burk R, Hill K. Reduced glutathione release into rat plasma by extrahepatic tissues. Am J Physiol 1995;269:396-9.
30. Michelutti L, Falter H, Certossi S, Marcotte B, Mazzuchin A. Isolation and purification of creatine kinase converting factor from human serum and its identification as carboxypeptidase N. Clin Biochem 1987;20:21-9.
31. Hinderks G, Frohlich J. Low serum creatine kinase values associated with the administration of steroids [Letter]. Clin Chem 1979;25:2050-1.
32. Mueller K, Swanson R. Possible captopril inhibition of creatine kinase: a case report [Abstract]. Clin Chem 1985;31:941.
33. Fraser A. Chemotherapy as a cause of low serum creatine kinase activity [Letter]. Clin Chem 1980;26:1629-30.
34. Young DS, ed. Effects of drugs on clinical laboratory tests, 4th ed. Washington, DC: AACC Press, 1995:185-9.